Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 571

1.
2.

Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes.

Glossop JR, Dawes PT, Hassell AB, Mattey DL.

J Rheumatol. 2005 Sep;32(9):1673-8.

PMID:
16142859
3.

Relationship between the tumor necrosis factor receptor II (TNF-RII) gene polymorphism and sTNF-RII plasma levels in healthy controls and in rheumatoid arthritis.

Tolusso B, Sacco S, Gremese E, La Torre G, Tomietto P, Ferraccioli GF.

Hum Immunol. 2004 Dec;65(12):1420-6.

PMID:
15603867
4.
5.

No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis.

Glossop JR, Nixon NB, Dawes PT, Hassell AB, Mattey DL.

J Rheumatol. 2003 Jul;30(7):1406-9.

PMID:
12858434
7.

Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure.

Nozaki N, Yamaguchi S, Shirakabe M, Nakamura H, Tomoike H.

Jpn Circ J. 1997 Aug;61(8):657-64.

8.
9.

Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients.

Spoettl T, Hausmann M, Klebl F, Dirmeier A, Klump B, Hoffmann J, Herfarth H, Timmer A, Rogler G.

Inflamm Bowel Dis. 2007 Jun;13(6):727-32.

PMID:
17260368
11.

Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.

Fabris M, Tolusso B, Di Poi E, Assaloni R, Sinigaglia L, Ferraccioli G.

J Rheumatol. 2002 Sep;29(9):1847-50.

PMID:
12233877
12.

Genetic determinants of circulating levels of tumor necrosis factor receptor II and their association with TNF-RII gene polymorphisms.

Vistoropsky Y, Ermakov S, Toliat MR, Trofimov S, Altmüller J, Malkin I, Nürnberg P, Livshits G.

Cytokine. 2010 Jul;51(1):28-34. doi: 10.1016/j.cyto.2010.04.013. Epub 2010 May 21.

PMID:
20488723
13.
14.

Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.

Vaiopoulos G, Boki K, Kapsimali V, Coulocheri S, Papadaki HA, Eliopoulos GD.

Haematologia (Budap). 1998;29(2):89-99.

PMID:
9728801
15.

Elevation of plasma-soluble tumour necrosis factor receptors (TNF-R) in sarcoidosis.

Nakayama T, Hashimoto S, Amemiya E, Horie T.

Clin Exp Immunol. 1996 May;104(2):318-24.

16.

Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with bulimia nervosa.

Nakai Y, Hamagaki S, Takagi R, Taniguchi A, Kurimoto F.

Clin Endocrinol (Oxf). 2000 Sep;53(3):383-8.

PMID:
10971457
17.

Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.

Culpan D, Cornish A, Love S, Kehoe PG, Wilcock GK.

Exp Gerontol. 2007 Jun;42(6):538-44. Epub 2007 Jan 30.

PMID:
17267158
18.

Genetic association studies of tumour necrosis factor alpha and beta and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis.

McDonnell GV, Kirk CW, Middleton D, Droogan AG, Hawkins SA, Patterson CC, Graham CA.

J Neurol. 1999 Nov;246(11):1051-8.

PMID:
10631637
19.

Enhanced expression and shedding of tumor necrosis factor (TNF) receptors from mononuclear leukocytes in human heart failure.

Nozaki N, Yamaguchi S, Yamaoka M, Okuyama M, Nakamura H, Tomoike H.

J Mol Cell Cardiol. 1998 Oct;30(10):2003-12.

PMID:
9799654
20.

Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.

Ribbens C, André B, Kaye O, Kaiser MJ, Bonnet V, de Groote D, Franchimont N, Malaise MG.

Eur Cytokine Netw. 2000 Dec;11(4):669-76.

Supplemental Content

Support Center